Results 301 to 310 of about 973,959 (388)
Mainstream Artificial Intelligence Technologies in Contemporary Ophthalmology
This review explores the latest artificial intelligence (AI) technologies in ophthalmology, focusing on four key data types: medical imaging, electronic health records, robotic‐assisted surgery, and genomics. It examines the structural features, use cases, clinical goals, and evaluation metrics of various AI algorithms, while also introducing emerging ...
Shiqi Yin+9 more
wiley +1 more source
Large cell neuroendocrine tumor of lung with hemorrhagic cerebral metastasis: A case report. [PDF]
Yadav AK+4 more
europepmc +1 more source
This article describes the integration of compliant bi‐stability in continuum robots. This integration leads to two variants of compliant bistable mechanism (CBM) integrated continuum robot segments, extending and locking. Results show that when used together, these CBM‐integrated segments allow the continuum robot to form custom shapes.
Muhammad Umer Khan Niazi+4 more
wiley +1 more source
Partially calcified giant hemorrhagic syringomyelia and hematomyelia. [PDF]
Duriqi A+3 more
europepmc +1 more source
Heparin-induced bullous hemorrhagic dermatosis: A report of 3 cases
Madeline R. Frizzell, MS+4 more
doaj
Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia
ABSTRACT Hereditary hemorrhagic telangiectasia (HHT) is the second‐most common inherited bleeding disorder worldwide, afflicting one in 4000–5000 people, and is the most morbid inherited bleeding disorder of women. HHT causes recurrent severe epistaxis, chronic gastrointestinal bleeding, heavy menstrual bleeding, and arteriovenous malformations in the ...
Hanny Al‐Samkari+5 more
wiley +1 more source
Practice patterns of vascular neurologists in timing anticoagulation for high risk stroke mechanisms versus atrial fibrillation. [PDF]
Khan F, Lu V, Yaghi S, Prabhakaran S.
europepmc +1 more source
Anti‐ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune‐Mediated TTP
Anti‐ADAMTS13 IgG antibodies titer trajectory from baseline to day 7–14 post‐TPE as a reliable approach to identify iTTP patients at risk of late response to the triplet therapy regimen. ABSTRACT Current triplet regimens associating therapeutic plasma exchange (TPE), immunosuppression with corticosteroids and rituximab, and caplacizumab have ...
Marie Robert+29 more
wiley +1 more source